Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma
Mitsuhito Hirano(The University of Tokyo), Arinobu Tojo(Tokyo Medical and Dental University)
Cited by 24
Related Papers
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters
|Journal of Clinical Investigation|2023|29